QIAGEN GmbH

QIAGEN offers a comprehensive range of integrated kits and reagents, complete automation systems as well as providing custom design and synthesis of siRNA for gene silencing.

QIAGEN (QGEN) has developed a comprehensive portfolio of more than 500 proprietary, consumable products and automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification. The product portfolio also includes diagnostic kits, tests and assays for human and veterinary molecular diagnostics.

QIAGEN acquired the Molecular Staging assets in 2004, which developed products based on its Multiple Displacement Amplification (MDA) technology.

Peer M. Schatz (CEO)

QIAGEN Strasse 1
40724 Hilden
Germany
Phone: +49 (0)2103-29-12000
Fax: +49 (0)2103-29-2200

QIAGEN also offers solutions for researchers using protein-based approaches in systems biology. The QIAexpress® system, a complete integrated solution for expression, purification, detection and assay of recombinant His-tagged proteins, is complimented by the comprehensive Qproteome range of proteomics sample preparation kits and the LiquiChip® multiplex bead-based assay platform.

Recent additions to the fast-growing range of QIAGEN protein products include unique solutions for in vitro protein synthesis and kits for the highly economical BioSprint 15 platform, which put automated protein purification within the reach of more protein researchers than ever before.

QIAGEN provides high-quality, innovative technologies for people working in research, functional genomics, drug discovery and development, molecular diagnostics, gene therapy as well as other fields of the life sciences. QIAGEN products, services and innovative technologies are renowned for increasing the reliability, speed and ease-of-use of molecular and systems biology techniques.